Clinical Trials Directory

Trials / Completed

CompletedNCT05269537

Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia

Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia. A Prospective Observational Study Using Transthoracic Echocardiography

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
19 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Cardiac output will be measured in healthy parturients undergoing cesarean delivery under spinal anesthesia

Detailed description

ASA-II women undergoing cesarean delivery under spinal anesthesia will be included. Cardiac output will be measured using transthoracic echocardiography at 4 time points: Baseline, after 10 minutes of intrathecal injection, after delivery, and after 1 hour of intrathecal injection. Spinal anesthesia will be administered with 2.5 ml bupivacaine 0.5% and fentanyl 15 μg.

Conditions

Interventions

TypeNameDescription
RADIATIONTransthoracic EchocardiographyMeasurement of cardiac output in supine position with left lateral tilt at baseline, at 10 minutes after intrathecal injection, immediately after delivery, and at 1 hour after intrathecal injection
PROCEDURESpinal AnesthesiaPerformed at the L3-L4 or L4-L5 interspace using 25-gauge spinal needle
DRUGIntrathecal BupivacaineBupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space
DRUGIntrathecal FentanylFentanyl 15 μg will be administered in the subarachnoid space
DRUGCrystalloid Coload 1000 mLRinger acetate 1000 mL will be administered over 10 minutes starting immediately after intrathecal injection
PROCEDURECesarean DeliveryLower segment cesarean section using the Pfannenstiel incision and uterine exteriorization
DRUGIntravenous EphedrineIntravenous ephedrine 3, 5, and 10 mg will be administered when Systolic blood pressure decreases below 90%, 80%, and 70% of baseline, respectively.
DRUGOxytocinIntravenous oxytocin 10 U in 500 mL Ringer acetate will be administered over 30 minutes starting immediately after delivery of the fetus

Timeline

Start date
2022-03-12
Primary completion
2022-07-02
Completion
2022-07-02
First posted
2022-03-08
Last updated
2022-11-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05269537. Inclusion in this directory is not an endorsement.